SANDOZ SUNITINIB
Active Ingredient: SUNITINIB
Product Overview
About SANDOZ SUNITINIB
SANDOZ SUNITINIB is a prescription medication containing the active ingredient SUNITINIB, a tyrosine kinase inhibitor used in the treatment of certain types of cancer. It is available in the form of capsules for oral administration.
Key Benefits & Uses
- Treatment of gastrointestinal stromal tumors (GIST) in patients who have been previously treated with imatinib mesylate.
- Treatment of advanced renal cell carcinoma (RCC) in patients who have failed prior therapy or are intolerant to other treatments.
- Treatment of pancreatic neuroendocrine tumors (PNET) in patients with a confirmed diagnosis of unresectable or metastatic disease.
Active Ingredient & Action
SUNITINIB works by inhibiting multiple receptor tyrosine kinases, including vascular endothelial growth factor receptors (VEGFRs), platelet-derived growth factor receptors (PDGFRs), and c-KIT. This action helps to slow or stop the growth of cancer cells and prevent the formation of new blood vessels that feed the tumor.
Important Notes
It is essential to use SANDOZ SUNITINIB exactly as prescribed by your doctor. Inform your doctor about any medical conditions, allergies, or medications you are taking before starting treatment. Common side effects may include diarrhea, fatigue, and nausea. Serious side effects can occur, including hypertension, bleeding, and liver damage. Monitor your blood pressure and liver function regularly while taking SANDOZ SUNITINIB.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
